AL6000 Alcohol Breathalyser The AL6000 analyzes a breath sample to detect alcohol in the lungs. This reading is then converted to blood alcohol concentration (BRAC – mg/L). The AL6000 uses an advanced oxide semiconductor sensor to detect alcohol. The AL6000 is the first and only breathalyzer that features Pre-Calibrated Alcohol Sensor Modules to eliminate the need for recalibration. Just snap out, snap in and you’re ready to go! 1 x Custom carry pouch 2 x Free batteries 5 x Plastic mouthpieces The UK Drink Drive Reading is 0.35mg/l on the AL6000 Unit we supply. Product Specification Color White Packaging Type Box Display Type Digital Application Law Enforcement Agencies Model Semiconductor Sensor Models Display LED Display Type of Mouthpiece Replaceable Analyzing time 5 s Clearing time 10 s Power Supply 1pc 9V battery Indication 00 to 0 40C or 0 00 to 0 400EL or Ing/L Minimum Order Quantity 1

The NB350 neonatal noninvasive ventilator is specially designed for neonatal ventilation, equipped with comprehensive NIV modes to provide reliable non-invasive respiratory support to meet the various needs of neonatal respiratory management. EasySync™ Technology The patented EasySync™ technology analyzes multi-channel parameters including gas flow and pressure without additional sensors, enabling accurate detection of spontaneous breath and improving synchrony in SNIPPV. The EasySync™ technology leads to a good synchronization performance comparable to electrical activity of the diaphragm (Edi). IOC (Intelligent Oxygen Control) The oxygen saturation of neonates tends to fluctuate, requiring caregivers to frequently adjust ventilator’s FiO2 settings. IOC (Intelligent Oxygen Control) achieves a closed-loop FiO2-SpO2 control by maintaining the patient’s SpO2 within the predetermined range, which reduces the workload of caregivers and improves patient safety. Integrated SpO2 monitoring for neonates in real time.1 Automatically adjust FiO2 setting by adaptive algorithm.2 Steadily maintain the SpO2 of neonates within the preset target range. Comfortable and Reliable Patient-interface The specialized patient-interface for the NB350 comes with a variety of sizes to fit for different clinical applications and patients. The ergonomic design with soft, skin-friendly material fully enhances the comfort of neonates throughout therapies. Bonnet/Headgear The bonnet/headgear integrate a fixings lot (seat) for pressure generator to avoid misposition and disconnection of patient-interface. Skin-friendly and breathable bonnet/headgear. Durable headgear hook-and-loop fastener allows easy and quick re-adjustment of the patient-interface. Infant Jet™ Pressure Generator Adjustable nasal prong/nasal mask positioning to adapt different facial orientations. Specifically designed to facilitate Coanda effect, significantly reducing respiratory resistance. Related Articles

Operate with Ease In the modern busy clinical environment, ease of use is a fundamental requirement for all medical devices. With this in mind, the new SV600 ventilators enable clinicians to set and deliver ventilation therapies quickly and easily via the intelligent ergonomic design and flat user interface. PulmoSight TM Utilizes numerical and graphical displays to show real time resistance, compliance and the spontaneous breathing status. Combined with the dynamic short trend display clinicians are able to monitor and evaluate changes in the patient's pulmonary ventilation and initiate the appropriate therapies. User configurable UI The SV600 ventilators offer exceptional user flexibility. Users are able to configure frequently used parameter controls by making them quick access shortcut keys in the UI. Also the ventilation mode keys can be arranged in order of frequency of use. This enables you to customize device in your way making parameter adjustment easier and quicker. Graphic guidelines The new intuitive graphical display enables users to learn quickly how to navigate and locate mode and parameter controls, thereby reducing errors and improving efficiency. Minimal Maintenance Routine maintenance requires no tools. The new 'door design' means that no tools are required to perform regular routine maintenance of the oxygen sensors, water trap, fan dust filter, HEPA air intake dust filter, etc. This ensures your new device always remains clean and clutter free. Intelligent Decision Making Ventilation modes and decision-supporting tools like Intelligent Assistant are developed on the basis of clinical needs and professional guidelines to help medical personnel calmly make clinical decisions. An extensive range of ventilation modes Smart ventilation solution: AMV TM + IntelliCycle TM Emergency solution: CPRVTM Sequential treatment regimen: Non-invasive ventilation & high flow oxygen therapy Dual channel auxiliary pressure measurements Lung protection kit Expandable Capabilities Securing your devices future is reliant on being able to expand your devices capabilities by interacting or integrating new concepts and technologies. The new SV800 / SV600 ventilators allow just this. Continue the latest electronic software and hardware, your new device is ready to embrace new technological advancement with ease. Integrated neonatal module with tidal volumes as low as 2 ml Plug & Play modules , including SpO2, mainstream or sidestream CO2 Backup air supply in case of air supply failure Seamlessly connected to the hospitals clinical information system via the Mindray BeneLink solution or eGateway solution Brand Mindray Model Name/Number SV600 Patient Age Group Neonatal, Adult, Paediatric Mounting Type ICU Operating Type Automatic Display Full color 15.6 inch Resolution 1920x1080 pixel Compliance IEC 60601-1-2 for EMC

In compliance with out-of-hospital patient transport standards such as EN1789, EN13718-1, IEC60601-1-12 and U.S. military standards, N1 is a highly competent solution for various out-of-hospital transport settings both on land and in air. The N1's exceptional reliability and strong performance enhance your confidence to provide seamless patient care during transport no matter intra or out of hospital. One monitor, Multiple solutions Mirror Mode Two-way screen or remote control functionality and viewing on both the 19" external display and the N1 unit - simultaneously. benevision-n1-fig2-2-pc BeneVision N1 as a Transport Monitor Enhanced data analysis greatly improves parameters' accuracy and anti-interference ability. Its fully integrated sidestream CO2 module monitors the patient's breathing situation by connecting with sampling line directly, freeing caregivers from the shackles of expanding external modules for transport. One monitor, Multiple solutions Mirror Mode Two-way screen or remote control functionality and viewing on both the 19" external display and the N1 unit - simultaneously. benevision-n1-fig2-2-pc BeneVision N1 as a Transport Monitor Enhanced data analysis greatly improves parameters' accuracy and anti-interference ability. Its fully integrated sidestream CO2 module monitors the patient's breathing situation by connecting with sampling line directly, freeing caregivers from the shackles of expanding external modules for transport. benevision-n1-fig2-1-pc BeneVision N1 as a Multi-Parameter Module Slide directly into the module slot or SMR of the N-Series monitor providing an expansive set of parameter measurements. When combined with our additional advanced parameter modules, this solution fits even the highest level of critical care environments. benevision-n1-fig2-3-pc Companion Mode Connect with N-Series host monitor via cable connection to N1 dock and have the ability for dual-screen monitoring and bi-directional control of the bedside monitor - expanding slot space for more advanced parameters and enhanced ICU workflow. Patient-Centric Data Collection When connected to a bedside patient monitor, advanced parameters collected from the host monitor such as AG and BIS, etc., will also be stored in N1 with trend data and alarm events reviewable even when it is disconnected.

Buy AccuTest COVID-19 IgG/IgM Rapid Test (Pack of 10 Tests) Online. COVID-19 IgG/IgM Rapid Test Kit is a qualitative immuno chromatographic assay for the detection of IgG & IgM antibodies produced against COVID-19 virus in human whole blood/Serum/ Plasma. COVID-19 IgG/IgM Rapid Test Kit is only intended for initial screening and reactive samples should be confirmed by a supplemental assay. Intended Use: COVID-19 IgG/IgM Rapid Test Kit is a qualitative immuno chromatographic assay for the detection of IgG & IgM antibodies produced against COVID-19 virus in human whole blood/Serum/ Plasma. COVID-19 IgG/IgM Rapid Test Kit is only intended for initial screening and reactive samples should be confirmed by a supplemental assay. SUMMARY & TEST DESCRIPTION: COVID-19 [Coronavirus Disease- 2019] is an infectious disease caused by SARS-CoV2 [Severe Acute Respiratory Syndrome coronavirus 2] virus, which is a contagious, novel strain of CoronaVirus that emerged from Wuhan, China in December 2019, which grew as a pandemic threatening human survival across the globe. The virus is thought to be of zoonotic origin and likely to have spread from large seafood and animal markets by human-animal contact in the city of Wuhan, where consumption of such products is in large. The virus causes respiratory infection with symptoms including fatigue, fever, shortness of breath, respiratory failure, renal failure and death. Patients can become infected with SARS-CoV-2 virus by person-person contact (through contact with a contaminated environment or person). The young and old (and other immune-compromised individuals) are most at risk of serious complications; however, approximately 20% of those infected can develop a critical condition. COVID-19 IgG/IgM Rapid Test device utilizes Anti-human IgG and Anti-human IgM antibodies as the capture molecules. COVID-19 Recombinant Antigens-colloidal gold conjugate are used as detection antigen. Intended Use: COVID-19 IgG/IgM Rapid Test Kit is a qualitative immuno chromatographic assay for the detection of IgG & IgM antibodies produced against COVID-19 virus in human whole blood/Serum/ Plasma. COVID-19 IgG/IgM Rapid Test Kit is only intended for initial screening and reactive samples should be confirmed by a supplemental assay. SUMMARY & TEST DESCRIPTION: COVID-19 [Coronavirus Disease- 2019] is an infectious disease caused by SARS-CoV2 [Severe Acute Respiratory Syndrome coronavirus 2] virus, which is a contagious, novel strain of CoronaVirus that emerged from Wuhan, China in December 2019, which grew as a pandemic threatening human survival across the globe. The virus is thought to be of zoonotic origin and likely to have spread from large seafood and animal markets by human-animal contact in the city of Wuhan, where consumption of such products is in large. The virus causes respiratory infection with symptoms including fatigue, fever, shortness of breath, respiratory failure, renal failure and death. Patients can become infected with SARS-CoV-2 virus by person-person contact (through contact with a contaminated environment or person). The young and old (and other immune-compromised individuals) are most at risk of serious complications; however, approximately 20% of those infected can develop a critical condition. COVID-19 IgG/IgM Rapid Test device utilizes Anti-human IgG and Anti-human IgM antibodies as the capture molecules. COVID-19 Recombinant Antigens-colloidal gold conjugate are used as detection antigen. PRECAUTIONS & WARNING 1. This package insert must be read completely before performing thetest. Failuretofollow directions in insert may yield inaccurate test results. 2. Test results should be read between 10 and 15 minutes after aspecimenisapplied to the sample well. Results read after 20 minutes may giveerroneousresults.3. Do not open the sealed pouch until you are ready to conduct theassay.Onceopened, the cassettes should be used immediately. 4. Do not use expired devices. 5. Bring all reagents to room temperature (15-30°C) prior to use. 6. Do not mix components from different kits. Use only the buffer suppliedalongwith the kit. 7. Wear protective clothing and disposable gloves while handling thekit reagentsand clinical specimens. Wash hands thoroughly after performing thetest. 8. Do not smoke, drink, or eat in areas where specimens or kit reagents arebeinghandled. 9. Dispose of all specimens and materials used to performthe test as biohazardouswaste. 10. Handle the negative and positive controls in the same manner as patientspecimens for operator protection. 11. Do not perform the test in a room with strong air flow, i.e. an electricfanorstrong air-conditioning. 12. Do not touch result window. 13. Use only for in-vitro diagnostic purpose.

Buy AccuTest H Pylori AB Rapid Card Test (50 Tests) Online from Accurex. The Helicobacter Pylori is a lateral flow chromatographic immunoassay for the qualitative detection of antibodies to H.pylori in human Whole Blood/Serum/Plasma. H Pylori test provides an aid in the diagnosis of infection with H.pylori. H.pylori is implicated in the etiology of a variety of gastrointestinal diseases, including duodenal and gastric ulcer, non-ulcer dyspepsia and active and chronic gastritis. h pylori symptoms are an ache or burning pain in your stomach (abdomen), Nausea, Loss of appetite, Frequent burping, Bloating & Unintentional weight loss NTENDED USE The H.pylori Antibody Rapid Test Card is a lateral flow chromatographic immunoassay for the qualitative detection of antibodies to H.pylori in human Whole Blood/Serum/Plasma. It provides an aid in the diagnosis of infection with H.pylori. INTRODUCTION H.pylori is implicated in the etiology of a variety of gastrointestinal diseases, including duodenal and gastric ulcer, non-ulcer dyspepsia and active and chronic gastritis. H.pylori infection is found in more than 90% of duodenal ulcer patients and in around 75% of all peptic ulcer sufferers. H.pylori infection is also more common in gastric cancer patients. The risk of gastric cancer has been estimated to be six-fold higher in H.pylori infected populations than in uninfected populations. H.pylori infections occur in human populations throughout the world. In developed countries, about 50% of the population may have H.pylori infection by the age of 60 years, while only 10-20% of adults in the third decade of life have it. Transmission is most probably by the fecal-oral or oral-oral route. Both invasive and non-invasive methods are used to diagnose H.pylori infection in patients with symptoms of gastrointestinal disease. Invasive methods include culture of gastric biopsy samples, histologic examination of stained biopsy specimens, or direct detection of the urease activity in the biopsy (CLO test). These methods need to obtain a biopsy sample by endoscopy.which is expensive,and usually results discomfort and risk to the patient.noninasive techniques include urea breath tests and serological methods. Urea breath test requires expensive laboratory equipment and moderate radiation exposure. Serologic tests are employed to detect antibodies as human immune response to H.pylori, for example the ELISA and the Western immunoblot. The H.pylori Antibody Rapid Test Card detect antibodies to H.pylori infection in human Whole Blood/Serum/Plasma. It is a noninvasive method and does not use radioactive isotopes. The test is easy to perform and requires no specialized equipment. Visual interpretation provides an accurate qualitative result. It is a useful on-site aid in the diagnosis of H.pylori infection. Diagnosis of H.pylori infection by antibody immunoassay can reduce the number of patients requiring endoscopy. PRINCIPLE The H.pylori Antibody Rapid Test Card is an immunoassay based on the principle of the double antigen-sandwich technique. During testing, a Whole Blood/Serum/Plasma specimen migrates upward by capillary action. The antibodies to H.pylori if present in the specimen will bind to the H.pylori conjugates. The immune complex is then captured on the membrane by the pre-coated H.pylori antigens, and a visible pink-purple line will show up in the test line region indicating a positive result. If antibodies to H.pylori are not present or are present below the detectable level, a pink-purple line will not form in the test line region indicating a negative result. To serve as a procedural control, a pink-purple line will always appear at the control line region, indicating that proper volume of specimen has been added and membrane wicking has occurred. Safety Information The H.pylori Antibody Rapid Test Card is limited to provide a qualitative detection. The intensity of the test line does not necessarily correlate to the concentration of the antibody in the blood. x The results obtained from this test are intended to be an aid in diagnosis only. Each physician must interpret the results in conjunction with the patient’s history, physical findings, and other diagnostic procedures. x A negative test result indicates that antibodies to H.pylori are either not present or at levels undetectable by the test. Direction for Use TEST PROCEDURE 1. Remove the test cassette from the sealed pouch and use it as soon as possible. 2. Place the test cassette on a clean and level surface. 3. For serum or plasma specimen: Hold the dropper vertically and transfer 3 drops of serum or plasma to the specimen well (S) of the test cassette, then start the timer. See illustration below. 4. For whole blood specimens: Hold the dropper vertically and transfer 1 drop of whole blood (approximately 30μl) to the specimen well(S) of the test cassette, then add 2 drops of buffer (approximately 70μl) and start the timer. 5. Read results at 15 minutes. Do not interpret the result after 20 minutes. Other Info STORAGE AND STABILITY x Store as packaged in the sealed pouch at 4-40℃. The kit is stable within the expiration date printed on the label. x Once open the pouch, the test should be used within one hour. Prolonged exposure to hot and humid environment will cause product deterioration.